- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 7/02 - Recovery or purification
Patent holdings for IPC class C12N 7/02
Total number of patents in this class: 1057
10-year publication summary
55
|
52
|
66
|
70
|
62
|
77
|
72
|
58
|
59
|
27
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bavarian Nordic A/S | 257 |
19 |
The Trustees of the University of Pennsylvania | 4329 |
18 |
Transgene S.A. | 126 |
10 |
Valneva Austria GmbH | 115 |
9 |
Cytiva BioProcess R&D AB | 303 |
9 |
BIA Separations d.o.o. | 17 |
8 |
Seqirus UK Limited | 428 |
8 |
Novartis AG | 10829 |
7 |
The Regents of the University of California | 19943 |
7 |
Kaneka Corporation | 4529 |
7 |
University of Florida Research Foundation, Inc. | 4029 |
7 |
Crucell Holland B.V. | 90 |
7 |
MedImmune, LLC | 491 |
7 |
Sartorius Stedim Biotech GmbH | 831 |
7 |
Takeda Vaccines, Inc. | 219 |
7 |
Ultragenyx Pharmaceutical Inc. | 178 |
7 |
uniQure IP B.V. | 84 |
7 |
Merck Sharp & Dohme LLC | 3742 |
7 |
Wisconsin Alumni Research Foundation | 3890 |
6 |
Association Francaise Contre Les Myopathies | 119 |
6 |
Other owners | 887 |